🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1/3 We are excited to announce that the ALTER-AKI trial has been funded by CIHR! This will allow for the trial to be expanded, and completed, across🇨🇦. CCCTG Canadian Nephrology Trials Network #CTTG Canadian Community ICU Research Network Edward (Ted) Clark MD MSc @JeannieCallum Ron Wald Sean Bagshaw

Last week was a big one for ALTER-AKI: received great news from CIHR AND first participants at Heart Institute were enrolled by all-star coordinator #RebeccaPorteous.

Finally in print! Part 1 of our QI study - describing the use and test characteristics of POCUS in patients with AKI! Stay tuned for part 2! Michael Woo Sydney Ruller Krista Wooller @epi_rad Edward (Ted) Clark MD MSc Ottawa IM theultrasoundjournal.springeropen.com/articles/10.11…

Sharing our latest work characterizing CHIP as a risk factor for acute kidney injury (AKI) using human cohort data and mouse models. Published today in Nature Medicine: nature.com/articles/s4159…

Kudos to the ICU research team NiagaraHealth for randomizing their first patient into the ALTER-AKI trial this past week! Jennifer Tsang Canadian Community ICU Research Network CCCTG Canadian Nephrology Trials Network #CTTG

Congrats to the KingstonHSC Queen’s CCM Program team for enrolling their 1st patient into The ALTER AKI Trial!! Michaela Hanley J Gordon Boyd @jeanniecallum @drsamsilver @docsibley John Muscedere CCCTG Canadian Nephrology Trials Network #CTTG

Best retrospective #POCUS study: Gaudreau-Simard M et al. Test characteristics of POCUS in patients with acute kidney injury. Ultrasound J 2024;16:15. Mathilde Gaudreau-Simard Michael Woo Sydney Ruller @epi_rad Edward (Ted) Clark MD MSc Krista Wooller 🔗doi.org/10.1186/s13089…

Congrats to @lakeridgehealth critical care doc Shannon Fernando as lead author on this systematic review of the role of methylene blue in septic shock! Great team of investigators that will continue to work on better understanding of this therapy. journals.lww.com/ccejournal/ful…

ALTER-AKI Trial hit a major milestone this week with our 100th participant enrolled! CCCTG Canadian Nephrology Trials Network #CTTG

For more discussion and to put these findings into perspective, read the accompanying commentary from Greg Hundemer of Ottawa Renal and Hohsen Agharazhii 🔗academic.oup.com/ajh/article-ab…

🎉Congratulations, Dr. Cory E. Goldstein! Winner of Université d'Ottawa | University of Ottawa Faculty of Medicine's Best Paper Award 2024 for "The Ottawa Statementment implementation guidance document for cluster randomized trials in hemodialysis setting". Find more about it @ rebrand.ly/mz8ej8e

Excited to see this finally in press!!! Shout-out to coauthors Swapnil Hiremath @hswapnil.medsky.social Abdulghani Kabli Oleksa Rewa Edward (Ted) Clark MD MSc and to Etienne Macedo and Ravindra L Mehta whose prior version we built upon. AJKD #nephCC #nephcrit #critcareneph #AKI sciencedirect.com/science/articl…